CP

Current Pharmaceutical Design

Current Pharmaceutical Design is a journal published by Bentham Science with ISSN 1381-6128 and eISSN 1873-4286. It has an Impact Factor of 2.8, a 5-year Impact Factor of 3.1, and a CiteScore of 5.9. The journal publishes themed issues and offers online manuscript submission, editorial information, author guidelines, and open access article availability.

Looking to publish in Current Pharmaceutical Design? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Pharmacology & Pharmacy
Impact Factor 2.8
Quartile Q2
Open Access Type Hybrid
ISSN 1381-6128
eISSN 1873-4286
Invitation Only No
Cost Range No page charges for review articles. Research articles category 1: US $950 per article inclusive of limited-time open access. Research articles category 2: US $490 per article excluding the Open Access option. Gold Open Access: US $3425 per article for general submissions and US $1900 per article for thematic issues. Quick Track publication fee: US $4845 per article.

Submission Instructions

Current Pharmaceutical Design accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The corresponding author must have approval from all listed authors for submission and publication of all versions of the manuscript.
Abstract A structured abstract is required for Review Articles. The abstract must not exceed 250 words. The abstract must be structured.
Manuscript Review Articles must be 6000-10000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must be divided into Title, Title page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations (if any), Consent for Publication, Availability of Data and Materials, Funding, Conflict of Interest, Acknowledgements, References, Appendices, Figures/Illustrations (if any), Chemical Structures (if any), Tables (if any), and Supportive/Supplementary Material (if any). The manuscript must include 6 to 8 keywords, a graphical abstract, a separate Authors' Contribution paragraph with a CRediT author statement, and disclosure of any significant AI use.
References Review Articles must contain 100 or more references. References must use the numerical Vancouver system. References must be cited sequentially in square brackets and listed in the same numerical order, with journal names abbreviated according to Index Medicus/MEDLINE and all authors listed without using "et al.".
Figures & Tables There is no restriction on the number of figures or tables that can be included online. Figures and tables must be embedded in the manuscript at their appropriate placement, and figures must also be provided as separate files. Each figure should contain a single illustration unless combined as one composite file for multipart figures, and each table must include a self-explanatory title or caption.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Mini-Reviews

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The corresponding author must have approval from all listed authors for submission and publication of all versions of the manuscript.
Abstract Abstract requirements are not specified.
Manuscript Mini-Reviews must be 3000-6000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must include 6 to 8 keywords, an "Authors' Contribution" paragraph with a CRediT author statement, and disclosure of any significant AI tool use.
References Mini-Reviews must contain 75 or more references. References must use the numerical Vancouver system. References must be cited sequentially in square brackets and listed in the same numerical order, with journal names abbreviated according to Index Medicus/MEDLINE and all authors listed without using "et al.".
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included with each article online. Figures and tables must be embedded in the manuscript text at their appropriate placement, and figure files must also be provided separately. Figures must be numbered consecutively and cited in sequence with legends provided, while tables must be numbered sequentially in Arabic numerals and include a self-explanatory title or caption.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Systematic Reviews

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The corresponding author must have approval from all listed authors for submission and publication of all versions of the manuscript.
Abstract A structured abstract is required for Systematic Reviews. The abstract must not exceed 250 words. The abstract must be structured with explicit subheadings. Explicit subheadings are required, and a registered systematic review must include the registration number as the last line of the abstract.
Manuscript Systematic Reviews must be 4000-6000 words excluding figures, structures, photographs, schemes, and tables. Systematic Reviews must address the methods used for selecting, locating, extracting, and synthesizing data. The manuscript must include 6 to 8 keywords, an 'Authors' Contribution' paragraph with a CRediT author statement, and disclosure of any significant AI tool use with authors taking responsibility for AI-generated content.
References Systematic Reviews must contain 100 or more references. References must use the numerical Vancouver system. References must be cited as sequential numbers in square brackets, listed in the same numerical order, use Index Medicus/MEDLINE journal abbreviations, include all authors without 'et al.,' and references must not be cited in the abstract.
Figures & Tables There is no restriction on the number of figures or tables that can be included online. Figures and tables must be embedded in the manuscript text at their appropriate placement, and figure files must also be uploaded separately. Each figure must be cited in sequence with a legend or caption, each table must be numbered sequentially and include a self-explanatory title or caption, and multi-part figures must be supplied as a single composite illustration file.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Meta-Analysis Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The copyright letter must be signed on behalf of all co-authors.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings. The abstract must include explicit subheadings.
Manuscript Systematic Reviews and Meta-Analysis Articles must be reported according to PRISMA guidelines. The title page must include 6 to 8 keywords, and the manuscript must include separate sections for Authors' Contribution, conflict of interest disclosure, and Availability of Data and Materials, with disclosure of significant AI tool use in the manuscript.
References References must follow the numerical Vancouver system. References must be numbered sequentially in square brackets in the text and listed in the same numerical order in the reference section, with all authors listed and no use of et al., and references must not be cited in the abstract.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the text at their appropriate placement, and figure files must also be provided separately. Figures must be numbered consecutively and cited in sequence with legends or captions provided, each figure should contain a single illustration unless combined as one composite file, and each table must have a self-explanatory title or caption and be numbered sequentially in Arabic numerals.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Research Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The corresponding author must have approval from all listed authors for submission and publication of all versions of the manuscript.
Abstract Research Articles must be accompanied by a structured abstract. The structured abstract must not exceed 250 words. The abstract must be structured with explicit subheadings.
Manuscript Research Articles must be 4000-6000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must be organized into sections including Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgements, and References, and it must begin with the title page and abstract followed by the main text. The manuscript must include 6 to 8 keywords, a graphical abstract, a CRediT authors' contribution statement, conflict of interest and funding sections, availability of data and materials, acknowledgements, and disclosure of significant AI use including image or data-related AI use in the manuscript.
References Research Articles must contain 75 or more references. References must use the numerical Vancouver system. References must be cited in numerical order in square brackets, listed in the same order, use Index Medicus/MEDLINE journal abbreviations, include all authors without using et al., and must not include abstracts, unpublished data, or personal communications.
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included online. Figures and tables must be embedded in the manuscript text at their appropriate placement, while figure files must also be provided separately. Each figure must be numbered consecutively and cited in sequence with a legend or caption, each figure should contain a single illustration with multipart figures combined into one file, and each table must be in Word table format with an explanatory title or caption.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Short Communications

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The corresponding author must have approval from all listed authors for submission and publication of all versions of the manuscript.
Abstract Abstract requirements are not specified.
Manuscript Short Communications must be 2000-3000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must include 6 to 8 keywords, a separate paragraph headed "Authors' Contribution," a CRediT author statement, and disclosure of any significant use of AI tools.
References Short Communications must contain 25 or more references. References must be listed in the numerical Vancouver system. References must be cited in square brackets and listed in the reference section in the same numerical order, with journal names abbreviated according to Index Medicus/MEDLINE and all authors listed without using "et al.".
Figures & Tables There is no restriction on the number of figures, tables, or additional files that can be included with each article online. Figures and chemical structures must be uploaded as separate files, while tables must be embedded in the text at their appropriate placement. Illustrations must be embedded in the text file and numbered consecutively, each figure should contain a single illustration or a single composite file for multipart figures, and each table must include an explanatory title or caption.
Reformat to Current Pharmaceutical Design using Livewrite Premium

Recent Publications

Kunxian Capsule Exerts Antitumor Effects by Activating the IL-17 Signaling Pathway to Inhibit the Proliferation, Apoptosis, Cell Cycle, and Induce Reactive Oxygen Species Production in C8166 Tumor Cells

Xiao-Dan Wang, Xiao-Na Ma, Chun-Sheng Fang, Ren-An Qin, Feng-Lei He, Yun-Bin Lin, Qiang Xu, Nan Li

10.2174/0113816128447050260521075026
View Publication

Receptor for Advanced Glycation End Products (RAGE) Ligand Axis as a Mediator of Inflammation and Oxidative Stress in Cancer: Implications for Cancer Progression and Therapeutic Targeting

Sandip Mondal, Payel Chakraborty, Souvik Ghatak, Manish Kumar Gautam, Tapan Kumar Mukherjee

10.2174/0113816128488085260604051040
View Publication

Emerging Trends in Targeted Molecular Therapies for Inflammatory Bowel Disease: Biologics and Small Molecules

Praveen Kumar Borra, Phool Chandra, Arvind Raghav, Anupama Koneru, Neetu Sachan, Manish Kumar Gautam

10.2174/0113816128417113260325071230
View Publication

Konjac Glucomannan in Cancer Therapeutics: Engineering Controlled Release System for 5-Fluorouracil

Rabab Fatima, Mokhtar Rejili, Amita Joshi Rana, Md Sadique Hussain

10.2174/0113816128437229260515190721
View Publication

Association Between Electron-Shuttling Capacity and Neuroprotective Potential of Huang-Lian-Jie-Du-Tang: A Bioelectrochemical, Biochemical and Computational Study

Aicee Julliane I. Aspuria, Bor-Yann Chen, Stephanie Claire M. Tiongson, Andrea Nicole A. Aguila, March Millenn G. Zamora, Cheng-Yang Hsieh, Chung-Chuan Hsueh, Kathlia A. De Castro-Cruz, Po-Wei Tsai

10.2174/0113816128458073260522073424
View Publication

Frequently asked questions

How long does it take to publish?

Quick Track allows online publication within 2 weeks of receipt of final approved galley proofs. Total publication time from first receipt of the manuscript to online publication is 10 weeks under Quick Track, subject to acceptance and author revision within one week. Revised papers are usually requested within 15 days, and revision time may vary from one to four weeks. Proofs should be returned within 48 hours.

Reformat to Current Pharmaceutical Design using Livewrite Premium

Is a cover letter required?

A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.

Reformat to Current Pharmaceutical Design using Livewrite Premium

What are the publication costs?

No page charges apply to review articles. Research articles category 1 cost US $950 per article inclusive of limited-time open access, and research articles category 2 cost US $490 per article excluding the Open Access option. Gold Open Access costs US $3425 per article for general submissions and US $1900 per article for thematic issues.

Reformat to Current Pharmaceutical Design using Livewrite Premium

Research Topics

Computational Drug Discovery Methods Nanoparticle-Based Drug Delivery RNA Interference and Gene Delivery Advanced Drug Delivery Systems Monoclonal and Polyclonal Antibodies Research Lipoproteins and Cardiovascular Health Tryptophan and brain disorders Synthesis and biological activity Cholinesterase and Neurodegenerative Diseases Receptor Mechanisms and Signaling Neuroscience and Neuropharmacology Research Diet and metabolism studies MicroRNA in disease regulation Cancer, Hypoxia, and Metabolism Inflammatory mediators and NSAID effects Cancer, Lipids, and Metabolism Neuropeptides and Animal Physiology Chemical Synthesis and Analysis Atherosclerosis and Cardiovascular Diseases Advancements in Transdermal Drug Delivery HIV/AIDS drug development and treatment Alzheimer's disease research and treatments Antiplatelet Therapy and Cardiovascular Diseases Radiopharmaceutical Chemistry and Applications Eicosanoids and Hypertension Pharmacology

Related Journals

MP
Molecular Pharmacology American Society for Pharmacology and Experimental Therapeutics
AA
Antimicrobial Agents and Chemotherapy American Society for Microbiology
MD
Marine Drugs Multidisciplinary Digital Publishing Institute
JO
Journal of Drug Delivery Science and Technology Elsevier BV
JO
Journal of Psychopharmacology SAGE Publishing
PD
Pediatric Drugs Adis, Springer Healthcare